Theinnate/general resistance system and the adaptive system are the two main subsystems of the immune system. To generate an efficient immune response, the innate and adaptive systems constantly interact with one another.
The innate immune system, also known as general resistance, consists of several defensive mechanisms that are constantly active and serve as the first line of defense against pathogenic substances. These responses, however, are not limited to a single pathogenic agent. Innate immune cells are selective for conserved molecular patterns seen on all microorganisms.
Adaptive immunity contains specialized immune cells and antibodies that target and eliminate foreign invaders while also remembering what those substances look like and creating a new immune response to prevent sickness in the future. Adaptive immunity can last a few weeks or months, or it might endure a long period, even for the rest of a person's life.
Humoral immunity and cell-mediated immunity are two forms of adaptive immune responses that allow the human body to protect itself against dangerous agents including bacteria, viruses, and poisons, in a targeted manner. While there is some overlap between these immune response arms - both rely on lymphoid cell functions - there are also some significant differences.
When foreign material - antigens - is recognized in the body, the body responds with an antibody-mediated reaction. Extracellular intruders, such as bacteria, are commonly found in this foreign material. B cell lymphocytes, a type of immune cell that makes antibodies after detecting a specific antigen, are principally responsible for this method.
Lymphocytes known as naive B cells circulate throughout the body via the lymphatic system. These cells produce antigen-specific molecules that are necessary for detecting infectious pathogens in the human body. When naive B cells in the lymphatic system come into contact with an antigen, they begin the differentiation process that results in the formation of memory B cells and effector B cells.
Memory B cells and effector B cells produce the same antigen-specific molecules as their parent naive B cell during this development. The activated memory B cells express these antigen-specific molecules on their surface with the help of T cell lymphocytes, which are activated by MHC class II receptors that recognize microbial-associated antigens. The effector B cells secrete these molecules in the blood to bind the antigen of interest.
Cell-mediated immunity, unlike humoral immunity, does not rely on antibodies to perform adaptive immunological activities. Mature T cells, macrophages, and the production of cytokines in response to an antigen are the main drivers of cell-mediated immunity.
To recognize intracellular target antigens, T cells that participate in cell-mediated immunity rely on antigen-presenting cells that have membrane-bound MHC class I proteins. The maturation and differentiation of naive T cells into helper or killer T cells are dependent on the binding specificity of MHC proteins to external antigens.
Cell-mediated immunity is activated when cells in the body are infected by a virus, bacterium, or fungus (intracellular invaders). T lymphocytes can detect malignant cells with the help of MHC class I proteins. Helper T cells, killer T cells, and macrophages are the three main kinds of lymphocytes involved in cell-mediated immunity.
When a "helper" T cell encounters an antigen-presenting cell in the body, it releases cytokines, which are signaling proteins. These cytokines cause "killer" T lymphocytes and macrophages to flock to the antigen-presenting cell in an attempt to eliminate it.
B cells activate humoral immunity, whereas T cells activate cell-mediated immunity. The major difference between humoral and cell-mediated immunity is that humoral immunity produces antigen-specific antibodies, whereas cell-mediated immunity does not. T lymphocytes, on the other hand, kill infected cells by triggering apoptosis.
Humoral immunity develops quickly, whereas cell-mediated immunity takes longer. Extracellular microorganisms and their poisons are targeted by humoral immunity. Intracellular microorganisms (such as bacteria) and tumor cells are targets of cell-mediated immunity.
The Ig, CD40, CD21, and Fc receptors are the humoral immunity's accessory receptors. The accessory receptors of cell-mediated immunity are CD2, CD3, CD4, CD8, CD28, and integrins. Humoral immunity recognizes the unprocessed antigens. In humoral immunity, plasma B cells release antibodies. Cytokines are released by T-cells. Tumor cells and transplants are immune to humoral immunity. Tumor cells and transplants are both affected by cell-mediated immunity.
T-cell responses, which are part of cell-mediated immunity, play a vital role in controlling viral infections. T-cells do this through developing effector activities such as the generation of chemokines and cytokines, which can have direct and indirect antiviral effects, as well as assisting in the overall immune response regulation.
Certain effector T-cells can kill virus-infected cells via cell-to-cell contact, providing an important mechanism of killing the host's cells, which serve as offspring virus generation sites. Immune responses mediated by cells are not only beneficial during the acute phase of viral infections, but they also help to create long-term immunological memory.
Humoral immunity is extremely important in both health and disease, and it can be both useful and harmful. Antibody-mediated protection against pathogens induced by vaccines or infections is crucial in host defense, but pathogen-specific antibodies can also promote infectious processes or drive pathology. Loss of immunological tolerance is linked to the generation of self-reactive antibodies, which can aggravate the condition, and loss of growth control can lead to a variety of B cell malignancies.
During her time at AZoNetwork, Emily has interviewed over 300 leading experts in all areas of science and healthcare including the World Health Organization and the United Nations. She loves being at the forefront of exciting new research and sharing science stories with thought leaders all over the world.
While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.
Nave B cells are lymphocytes that circulate throughout the body in the lymphatic system. These lymphocytes express a variety of antigen-specific molecules that are essential for the detection of infectious agents in the human body. Whenever nave B cells encounter an antigen in the lymphatic system, they undergo a differentiation process that leads to the creation of memory B cells and effector B cells.
During this differentiation, memory B cells and effector B cells produce the same antigen-specific molecules as their parent nave B cell. With the help of T cell lymphocytes, in turn activated by MHC class II receptors that recognize microbial-associated antigens, the activated memory B cells express these antigen-specific molecules on their surface while the effector B cells secrete these molecules in the blood to bind the antigen of interest.
When an antigen matching the antigen-binding site binds to a nave or memory B cell, it activates the B cell to produce and secrete more antigen-specific antibodies. Once a B cell fully matures, it is known as a plasma cell and will continue to produce and secrete antigen-specific antibodies for the remainder of its life cycle.
Antibodies can also participate in processes that lead to the lysis or killing of infected or antigen-presenting cells through the activation of the complement cascade or interaction with effector cells and release of cytokines. The complement system is a part of innate immunity that enhances the ability of antibodies and lymphocytes to clear the body of pathogens and infected cells. Lastly, antibodies that coat pathogens or infected cells can attract (opsonize) and become internalized by macrophages during phagocytosis.
Humoral immunity depends on lymphocytes to confer protection against infection through antibody-mediated functions, but it is not the only form of adaptive immunity that involves bone marrow lymphocytes.
T cells involved in cell-mediated immunity rely on antigen-presenting cells that contain membrane-bound MHC class I proteins in order to recognize intracellular target antigens. The binding specificity between MHC proteins and foreign antigens is essential for the maturation and differentiation of nave T cells into helper or killer T cells.
Cell-mediated immunity typically comes into play at body sites where cells are infected by a virus, bacteria, or fungi (intracellular invaders). With the assistance of MHC class I proteins, T cells can also recognize cancerous cells.
What is humoral immunity?
Humoral immunity is an antibody-mediated response that occurs when foreign material - antigens - are detected in the body. This foreign material typically includes extracellular invaders such as bacteria This mechanism is primarily driven by B cell lymphocytes, a type of immune cell that produces antibodies after the detection of a specific antigen.
How are antibodies produced?
Each B cell produces its own set of antibodies with unique antigen-specific binding sites. Initially, nave B cells produce antibodies that remain bound to the cellular surface so that their exposed antigen-binding sites can detect potential pathogens, toxins and foreign material. This surface-bound form of an antibody is known as an immunoglobulin.When an antigen matching the antigen-binding site binds to a nave or memory B cell, it activates the B cell to produce and secrete more antigen-specific antibodies. Once a B cell fully matures, it is known as a plasma cell and will continue to produce and secrete antigen-specific antibodies for the remainder of its life cycle.
3a8082e126